Here are the latest ADHD news highlights across reputable outlets and research sources.
Overview
- ADHD research in 2024–2025 continues to refine understanding of prevalence, long-term outcomes, and treatment safety, with emphasis on early intervention and real-world impacts of medication. This reflects ongoing efforts to translate genetics, neuroimaging, and epidemiology into practical guidance for clinicians and patients.
Key developments
-
Prevalence and diagnostic practices
- Recent syntheses indicate ADHD prevalence remains stable, with improved tools for diagnosis and monitoring, rather than a sudden rise in cases. This helps counter misconceptions of an “epidemic” and supports sustained access to assessment services.
- Large studies continue to examine how early identification and consistent treatment affect long-term outcomes, including life expectancy and risk of adverse events.
-
Treatment safety and outcomes
- Several major reviews and reports highlight that ADHD medications, when prescribed appropriately, are associated with reduced risk of adverse outcomes (e.g., suicidality, accidental injuries) particularly when initiated soon after diagnosis and monitored. This informs risk–benefit discussions with patients and families.
- Ongoing investigations assess medication safety during pregnancy and potential interactions with comorbid conditions, underscoring the need for individualized treatment plans in special populations.
-
Related topics and misconceptions
- News coverage continues to address public understanding of ADHD and treatment, including media influence on treatment decisions and the importance of accurate information about risks and benefits.
- Studies exploring comorbidities and shared neurobiological pathways (e.g., genetics and data science approaches to adult ADHD) are expanding diagnostic and intervention frameworks for adults with ADHD.
Representative sources you can check
- ADDitude magazine: editorial roundups of top ADHD news and research from 2025, including prevalence, outcomes, and treatment safety.[1]
- CBS News: recent updates on ADHD research and related public health questions, including pregnancy considerations and large-scale outcomes.[2]
- CHADD: ongoing ADHD news and education for adults, with analyses of gaps in recognition and support, and lifestyle strategies.[3]
- WebMD and Science Daily: ongoing coverage of new studies on ADHD risks, treatments, and related conditions.[4][5]
If you’d like, I can tailor a brief digest for you (e.g., by topic like treatment safety, adult ADHD, or pregnancy considerations) or pull the very latest headlines from specific outlets you trust. I can also summarize a selected article in plain language and note any practical implications for you or someone you know in Los Angeles. Would you like a concise daily brief or a deeper dive into one of these areas?
Sources
"It's as definitive as we're going to get," CBS News medical contributor Dr. Céline Gounder said of the new research, which found no connection between Tylenol and autism or ADHD. "It's as definitive as we're going to get," CBS News medical contributor Dr. Céline Gounder said of the new research, which found no connection between Tylenol and autism or ADHD. … Mille Haywood is overcoming her own mental health challenges and helping others with clothes that offer "comfort hugs," and a "Slay-DHD"...
www.cbsnews.comADHD NEWSSTAND FOR ADULTS contents Why ADHD Is Often Missed in Asian American Communities Podcast & Video Review Patrick Goh, PhD, explains how research gaps, stigma, cultural expectations, and the model minority myth can affect ADHD recognition, diagnosis, and support. Watch What Else Can I Do? Lifestyle Support for ADHD Featuring Stephanie Sarkis, PhD Stephanie…
chadd.orgADHD affects an estimated 3% to 5% of children and adults in the U.S. Get ADD and ADHD information here including its causes, diagnosis, and promising treatments.
www.webmd.comRead the latest medical research on ADHD. Learn about the symptoms of ADD and ADHD. Find out about ADHD tests, a recommended diet, medication and new treatment options.
www.sciencedaily.comAn editorial round-up of the scientific studies and findings most likely to impact our readers’ lives and health.
www.additudemag.comRead the latest medical research on ADD, ADHD and related attention deficit disorders. Find information on ADD and ADHD tests, diagnosis methods, ADHD drugs and new approaches to ADHD treatment.
www.sciencedaily.comLatest news on Attention Deficit Hyperactivity Disorder, commonly known as ADHD, including updates on treatment, medicines, studies, and heath care provision.
www.newsnow.co.ukKelli Lehto, Associate Professor of Neuropsychiatric Genomics at the University of Tartu, is leading a prestigious European Research Council (ERC) grant project that brings together genetics, psychology, and data science to investigate the causes of attention deficit hyperactivity disorder (ADHD) in adults and enhance diagnostic methods.
chadd.orgGet the latest news on ADD-ADHD management, research, treatment advancements and more from WebMD.
www.webmd.com